Loading chat...
OH SB220
Bill
Status
Introduced
8/30/2021
Primary Sponsor
Hearcel Craig
Click for details
AI Summary
- Enacts section 3902.62 of the Revised Code to cap cost sharing for prescription insulin drugs used to treat diabetes
- Limits cost sharing to a maximum of $35 per 30-day supply for covered prescription insulin drugs in health benefit plans amended, issued, or renewed on or after the bill's effective date
- Applies the $35 cap regardless of the amount or type of insulin needed to fill the prescription
- Requires cost sharing to be charged on a per-prescription-fill basis
- Overrides section 3901.71 of the Revised Code regarding cost-sharing limitations
Legislative Description
Cap cost sharing for prescription insulin drugs
Health and Human Services : Health Care
Last Action
Refer to Committee: Insurance
9/8/2021
Committee Referrals
Insurance9/8/2021
Full Bill Text
No bill text available